Endocrine Abstracts

Introduction

After the emergence of the COVID 19 pandemic, many publications have interested in type 2 diabetes mellitus with a dearth of papers regarding type 1 diabetes mellitus (T1DM), especially new-onset type 1 diabetes which entails a special concern. We report herein the experience of a single tertiary care Center.

Methods

A retrospective observational study including New-onset T1D patients between March 2020 and December 2020 comparing with the same period of the year 2019. Data were collected from patient charts, and teleconsultation reports.

Results

Between Mars 2020(Lockdown Covid-19) until December 2020, 29 patients have been admitted to our Department. The pediatric population represent 65.5% of them and the sex ratio H/F is 1.27. Compared to the same period of the last year we observed an increase of 22%. Severe ketoacidosis (DKA) was observed in 28% of patients in 2020 and 17.4 of patients in 2019 (P<0.001). The mean baseline Hba1c was: 12.72% (± 1.6). The follow-up was ensured using teleconsultation and the therapeutic adjustment was made daily for 2 weeks after discharge. No episode of decompensation or severe hypoglycemia was noted during follow-up and the mean Hb1Ac at 3 months was 7.2%

Conclusion

Several papers report an increase in the number of New-onset T1D diabetes and the severity of ketoacidosis DKA during the COVID-19 pandemic. The potential bidirectional link between COVID 19 and T1DM is being investigated. Telemedicine seems to be an effective approach for the management of patients with New-onset T1D.